Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

Company says it will seek approval of Alzheimer’s drug

WorldNews Tuesday, 22 October 2019
Company says it will seek approval of Alzheimer’s drugThe drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer’s disease. It’s a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement Tuesday is a surprise because the company earlier this year stopped two studies of the drug when partial results suggested it was not working. Biogen says a new analysis of more results suggest it has some benefits at the highest dose. The drug company Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat...
0
shares
ShareTweetSavePostSend
 
Credit: Rumble - Published < > Embed
News video: Biogen resurrects Alzheimer's drug, stock soars

Biogen resurrects Alzheimer's drug, stock soars 00:59

Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer&apos;s treatment after abandoning the drug earlier this year. Freddie Joyner has the story.

Recent related videos from verified sources

Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says [Video]Novartis Still a Buy Despite Controversy Over Blockbuster Drug, Jim Cramer Says

Novartis and its CEO may have gotten a black eye amid a dust-up over tainted research, but the pharma giant is still a buy, according to Jim Cramer during his exclusive video-conference call on..

Credit: The Street     Duration: 02:30Published

'That's just stupid' Young patient reacts to company pulling life-saving cancer drug [Video]'That's just stupid' Young patient reacts to company pulling life-saving cancer drug

A company took a life-saving cancer drug out of production, and now there's a nationwide shortage.

Credit: NewsChannel 5 Nashville     Duration: 02:16Published


Recent related news from verified sources

Supernus Pharmaceuticals seeks FDA approval for ADHD drug

The fate of a local company’s treatment for attention deficit hyperactivity disorder is now in regulators’ hands. Supernus Pharmaceuticals Inc. (NASDAQ:...
bizjournals Also reported by •Proactive Investors

Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease

Hope Biosciences Receives FDA Approval to Commence Groundbreaking Stem Cell Clinical Trial for Alzheimer’s Disease
HOUSTON--(BUSINESS WIRE)--Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease,...
Business Wire

You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.